Table 4 : Comparison of clinical data (N=250).


  Start of treatment
(mean ± S.D.)
At least 5 months of treatment
(mean ± S.D.)
p-value*

DBP / SBPa, mmHg 80.3 ± 8.6 / 136.5 ± 14.9 78.6 ± 8.3 / 132.7 ± 12.9 <0.01
HRb, bpm 75.4 ± 7.8 74.2 ± 7.6 <0.01
Cholesterolc, (mmol/l) 5.1 ± 1 4.8 ± 0.9 <0.01
LDLd (mmol/l) 2.9 ± 0.9 2.7 ± 0.8 <0.01
HDLe (mmol/l) 1.4 ± 0.4 1.4 ± 0.5 >0.05
Triglyceridesf (mmol/l) 4.3 ± 2.8 3.7 ± 1.9 <0.01

Missing data, an=4, bn=25, cn=5, dn=33, en=34, fn=17.
*T-test, DBP, diastolic blood pressure; SBP, systolic blood pressure; HR, heart rate; S.D., standard deviation.

Bellido-Guerrero et al.Journal of Diabetes Research and Clinical Metabolism  2013 2:20DOI : 10.7243/2050-0866-2-20